Population Pharmacokinetic, Pharmacogenetic, and Pharmacodynamic Analysis of Cyclophosphamide in Ethiopian Breast Cancer Patients
Cyclophosphamide (CPA) containing chemotherapy regimen is the standard of care for breast cancer treatment in sub-Saharan Africa. Wide inter-individual variations in pharmacokinetics (PK) of cyclophosphamide (CPA) influence the efficacy and toxicity of CPA containing chemotherapy. Data on the pharma...
Main Authors: | Jemal Hussien Ahmed, Eyasu Makonnen, Ronald Kuteesa Bisaso, Jackson Kijumba Mukonzo, Alan Fotoohi, Abraham Aseffa, Rawleigh Howe, Moustapha Hassan, Eleni Aklillu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00406/full |
Similar Items
-
<i>CYP2D6</i> Genotype Predicts Plasma Concentrations of Tamoxifen Metabolites in Ethiopian Breast Cancer Patients
by: Jemal Hussien Ahmed, et al.
Published: (2019-09-01) -
Predictors of Efavirenz Plasma Exposure, Auto-Induction Profile, and Effect of Pharmacogenetic Variations among HIV-Infected Children in Ethiopia: A Prospective Cohort Study
by: Adugna Chala, et al.
Published: (2021-12-01) -
Impact of Population and Pharmacogenetics Variations on Efavirenz Pharmacokinetics and Immunologic Outcomes During Anti-Tuberculosis Co-Therapy: A Parallel Prospective Cohort Study in Two Sub-Sahara African Populations
by: Sabina Mugusi, et al.
Published: (2020-02-01) -
Study on consequences for interaction of myricetin with canagliflozin: A special attention to pharmacokinetics and pharmacodynamics of drug
by: Naga Raju Kandukoori, et al.
Published: (2023-01-01) -
Stimulus – Response mechanistic modeling of pharmacodynamic drug-drug interaction: Extension of the operational receptor model of agonism
by: Kuteesa Ronald Bisaso, et al.
Published: (2022-01-01)